Market Research Report

Global Rheumatoid Arthritis Market Report By Treatment (Symptomatic Treatment, Intermediate Corticosteroid Treatment, Disease Modifying Anti-Rheumatic Drug {DMARD} Therapies), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies And Drug Stores) And By Regions - Industry Trends, Size, Share, Growth, Estimation And Forecast, 2021-2028

ID:VMR11210170
March 2022
Report Formats: Electronic (PDF), MS EXCEL
As per this study the Global Rheumatoid Arthritis Market was valued USD XX BN (by revenue) in 2021 and is anticipated to reach USD XX BN by 2028 with a CAGR of X%.
 
Rheumatoid arthritis is a chronic autoimmune disorder that majorly affects the body joints. Initially, it affects joints of hands and toes, knees, ankles, elbows, hips but in case of severity may affect non-joint structures such as skin, lungs, blood vessels, nerve tissue and bone marrow. Common symptoms of rheumatoid arthritis are joint pain, soft and swollen joints along with constant fatigue, fever and weight loss.
 
Objectives of the Study:
  • Define and measure the global rheumatoid arthritis market
  • Revenue forecast of the global rheumatoid arthritis market and its various sub-segments with respect to main geographies
  • Analyze and identify major market trends along with the factors driving or inhibiting the market growth
  • Study the company profiles of the major market players with their market share
  • Analyze competitive developments
 
Market Dynamics
 
Rising count of patients suffering from arthritis and growing geriatric population are the key drivers driving the market growth. Rising adoption of generic drugs and novel therapies to treat the condition is fueling the demand of rheumatoid arthritis drugs. However, high cost of treatment may hinder the market growth in forecasting period.
 
This detailed market study is centered on the data obtained from multiple sources and is analyzed using numerous tools including porter’s five forces analysis, market attractiveness analysis and value chain analysis. These tools are employed to gain insights of the potential value of the market facilitating the business strategists with the latest growth opportunities. Additionally, these tools also provide a detailed analysis of each application/product segment in the global market of rheumatoid arthritis.
 
Market Segmentation
 
The broad rheumatoid arthritis market has been sub-grouped into treatment and distribution channel. The report studies these subsets with respect to the geographical segmentation. The strategists can gain a detailed insight and devise appropriate strategies to target specific market. This detail will lead to a focused approach leading to identification of better opportunities.
 
By Treatment
  • Symptomatic Treatment
  • Intermediate Corticosteroid Treatment
  • Disease Modifying Anti-Rheumatic Drug {DMARD} Therapies
    • Conventional DMARD
    • Biologic DMARD
 
By Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Drug Stores
 
Regional Analysis
 
Furthermore, the report comprises of the geographical segmentation, which mainly focuses on current and forecast demand for rheumatoid arthritis in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The report further focuses on demand for individual application segments in all the regions.
 
Global Rheumatoid Arthritis Market Share by Region (Representative Graph)
 
Global Rheumatoid Arthritis Market Share
 
The report also covers detailed competitive landscape including company profiles of key players operating in the global market. The key players in the rheumatoid arthritis market include AbbVie Inc., Amgen Inc., Bristol-Myers Squibb Company, Eli Lilly & Company, F. Hoffman-La Roche AG, Johnson & Johnson, Pfizer Inc., Sanofi SA, Sobi Inc., UCB S.A., and others. An in-depth view of the competitive outlook includes future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other developments with information in terms of H.Q.
 
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1 . PREFACE
       1.1. Report Description
           1.1.1. Objective
           1.1.2. Target Audience
           1.1.3. Unique Selling Proposition (USP) & offerings
       1.2. Research Scope
       1.3. Research Methodology
           1.3.1. Market Research Process
           1.3.2. Market Research Methodology
 
2 . EXECUTIVE SUMMARY
       2.1. Highlights of Market
       2.2. Global Market Snapshot
 
3 . RHEUMATOID ARTHRITIS – INDUSTRY ANALYSIS
       3.1. Introduction - Market Dynamics
       3.2. Market Drivers
       3.3. Market Restraints
       3.4. Opportunities
       3.5. Industry Trends
       3.6. Porter’s Five Force Analysis
       3.7. Market Attractiveness Analysis
           3.7.1 Market Attractiveness Analysis By Treatment
           3.7.2 Market Attractiveness Analysis By Distribution Channel
           3.7.3 Market Attractiveness Analysis By Region
 
4 . VALUE CHAIN ANALYSIS
       4.1. Value Chain Analysis
       4.2. Raw Material Analysis
           4.2.1. List of Raw Materials
           4.2.2. Raw Material Manufactures List
           4.2.3. Price Trend of Key Raw Materials
       4.3. List of Potential Buyers
       4.4. Marketing Channel
           4.4.1. Direct Marketing
           4.4.2. Indirect Marketing
           4.4.3. Marketing Channel Development Trend
 
5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK
       5.1. Impact Analysis of Covid-19 Outbreak
           5.1.1. Direct Impact on Production
           5.1.2. Supply Chain and Market Disruption
           5.1.3. Financial Impact on Firms and Financial Markets
       5.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
       5.3. Market: Pre V/S Post COVID-19
       5.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic 
       5.5. COVID-19: Micro and Macro Factor Analysis
 
6 . GLOBAL RHEUMATOID ARTHRITIS MARKET ANALYSIS BY TREATMENT
       6.1 Overview by Treatment
       6.2 Historical and Forecast Data
       6.3 Analysis by Treatment
       6.4 Symptomatic Treatment Historic and Forecast Sales by Regions
       6.6 Intermediate Corticosteroid Treatment Historic and Forecast Sales by Regions
       6.5 Disease Modifying Anti-Rheumatic Drug {DMARD} Therapies Historic and Forecast Sales by Regions
 
7 . GLOBAL RHEUMATOID ARTHRITIS MARKET ANALYSIS BY DISTRIBUTION CHANNEL
       7.1 Overview by Distribution Channel
       7.2 Historical and Forecast Data
       7.3 Analysis by Distribution Channel
       7.4 Hospital Pharmacies Historic and Forecast Sales by Regions
       7.5 Retail Pharmacies Historic and Forecast Sales by Regions
       7.6 Drug Stores Historic and Forecast Sales by Regions
 
8 . GLOBAL RHEUMATOID ARTHRITIS MARKET ANALYSIS BY GEOGRAPHY
       8.1. Regional Outlook
       8.2. Introduction
       8.3. North America Sales Analysis
           8.3.1. Overview, Historic and Forecast Sales Analysis
           8.3.2. North America By Segment Sales Analysis
           8.3.3. North America By Country Sales Analysis
           8.3.4. United State Sales Analysis
           8.3.5. Canada Sales Analysis
           8.3.6. Mexico Sales Analysis
       8.4. Europe Sales Analysis
           8.4.1. Overview, Historic and Forecast Sales Analysis
           8.4.2. Europe by Segment Sales Analysis
           8.4.3. Europe by Country Sales Analysis
           8.4.4. United Kingdom Sales Analysis
           8.4.5. France Sales Analysis
           8.4.6. Germany Sales Analysis
           8.4.7. Italy Sales Analysis
           8.4.8. Russia Sales Analysis
           8.4.9. Rest Of Europe Sales Analysis
       8.5. Asia Pacific Sales Analysis
           8.5.1. Overview, Historic and Forecast Sales Analysis
           8.5.2. Asia Pacific by Segment Sales Analysis
           8.5.3. Asia Pacific by Country Sales Analysis
           8.5.4. China Sales Analysis
           8.5.5. India Sales Analysis
           8.5.6. Japan Sales Analysis
           8.5.7. South Korea Sales Analysis
           8.5.8. Australia Sales Analysis
           8.5.9. Rest Of Asia Pacific Sales Analysis
       8.6. Latin America Sales Analysis
           8.6.1. Overview, Historic and Forecast Sales Analysis
           8.6.2. Latin America by Segment Sales Analysis
           8.6.3. Latin America by Country Sales Analysis
           8.6.4. Brazil Sales Analysis
           8.6.5. Argentina Sales Analysis
           8.6.6. Peru Sales Analysis
           8.6.7. Chile Sales Analysis
           8.6.8. Rest of Latin America Sales Analysis
       8.7. Middle East & Africa Sales Analysis
           8.7.1. Overview, Historic and Forecast Sales Analysis
           8.7.2. Middle East & Africa by Segment Sales Analysis
           8.7.3. Middle East & Africa by Country Sales Analysis
           8.7.4. Saudi Arabia Sales Analysis
           8.7.5. UAE Sales Analysis
           8.7.6. Israel Sales Analysis
           8.7.7. South Africa Sales Analysis
           8.7.8. Rest Of Middle East And Africa Sales Analysis
 
9 . COMPETITIVE LANDSCAPE OF THE RHEUMATOID ARTHRITIS COMPANIES
       9.1. Rheumatoid Arthritis Market Competition
       9.2. Partnership/Collaboration/Agreement
       9.3. Merger And Acquisitions
       9.4. New Product Launch
       9.5. Other Developments
 
10 . COMPANY PROFILES OF RHEUMATOID ARTHRITIS INDUSTRY
       10.1. Top Companies Market Share Analysis
       10.2. Market Concentration Rate
       10.3. AbbVie Inc.
           10.3.1. Company Overview
           10.3.2. Company Revenue
           10.3.3. Products
           10.3.4. Recent Developments
       10.4. Amgen Inc.
           10.4.1. Company Overview
           10.4.2. Company Revenue
           10.4.3. Products
           10.4.4. Recent Developments
       10.5. Bristol-Myers Squibb Company
           10.5.1. Company Overview
           10.5.2. Company Revenue
           10.5.3. Products
           10.5.4. Recent Developments
       10.6. Eli Lilly & Company
           10.6.1. Company Overview
           10.6.2. Company Revenue
           10.6.3. Products
           10.6.4. Recent Developments
       10.7. F. Hoffman-La Roche AG
           10.7.1. Company Overview
           10.7.2. Company Revenue
           10.7.3. Products
           10.7.4. Recent Developments
       10.8. Johnson & Johnson
           10.8.1. Company Overview
           10.8.2. Company Revenue
           10.8.3. Products
           10.8.4. Recent Developments
       10.9. Pfizer Inc.
           10.9.1. Company Overview
           10.9.2. Company Revenue
           10.9.3. Products
           10.9.4. Recent Developments
       10.10. Sanofi SA
           10.10.1. Company Overview
           10.10.2. Company Revenue
           10.10.3. Products
           10.10.4. Recent Developments
       10.11. Sobi Inc.
           10.11.1. Company Overview
           10.11.2. Company Revenue
           10.11.3. Products
           10.11.4. Recent Developments
       10.12. UCB S.A.
           10.12.1. Company Overview
           10.12.2. Company Revenue
           10.12.3. Products
           10.12.4. Recent Developments
       10.13. Others.
           10.13.1. Company Overview
           10.13.2. Company Revenue
           10.13.3. Products
           10.13.4. Recent Developments
 
 *Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies
 
 LIST OF TABLES
 

  •  Market Snapshot
  •  Drivers : Impact Analysis
  •  Restraints : Impact Analysis
  •  List of Raw Material
  •  List of Raw Material Manufactures
  •  List of Potential Buyers
  •  COVID-19 Impact Analysis by Production, Import, Export and Demand
  •  Pre V/S Post COVID-19
  •  Estimated Impact Of The Coronavirus (Covid-19) Epidemic
  •  COVID-19: Micro and Macro Factor Analysis
  •  Analysis by Treatment (USD MN)
  •  Symptomatic Treatment Market Sales by Geography (USD MN)
  •  Intermediate Corticosteroid Treatment Market Sales by Geography (USD MN)
  •  Disease Modifying Anti-Rheumatic Drug {DMARD} Therapies Market Sales by Geography (USD MN)
  •  Analysis Market by Distribution Channel (USD MN)
  •  Hospital Pharmacies Market Sales by Geography (USD MN)
  •  Retail Pharmacies Market Sales by Geography (USD MN)
  •  Drug Stores Market Sales by Geography (USD MN)
  •  Global Rheumatoid Arthritis Market Sales by Geography (USD MN)
  •  North America Market Analysis (USD MN)
  •  United State Market Analysis (USD MN)
  •  Canada Market Analysis (USD MN)
  •  Mexico Market Analysis (USD MN)
  •  Europe Market Analysis (USD MN)
  •  Europe Market Estimate by Country (USD MN)
  •  United Kingdom Market Analysis (USD MN)
  •  France Market Analysis (USD MN)
  •  Germany Market Analysis (USD MN)
  •  Italy Market Analysis (USD MN)
  •  Russia Market Analysis (USD MN)
  •  Spain Market Analysis (USD MN)
  •  Rest of Europe Market Analysis (USD MN)
  •  Asia Pacific Market Analysis (USD MN)
  •  China Market Analysis (USD MN)
  •  Japan Market Analysis (USD MN)
  •  India Market Analysis (USD MN)
  •  South Korea Market Analysis (USD MN)
  •  Australia Market Analysis (USD MN)
  •  Rest of Asia Pacific Market Analysis (USD MN)
  •  Latin America Market Analysis (USD MN)
  •  Brazil Market Analysis (USD MN)
  •  Argentina Market Analysis (USD MN)
  •  Peru Market Analysis (USD MN)
  •  Chile Market Analysis (USD MN)
  •  Rest of Latin America Market Analysis (USD MN)
  •  Middle East & Africa Market Analysis (USD MN)
  •  Saudi Arabia Market Analysis (USD MN)
  •  UAE Market Analysis (USD MN)
  •  Israel Market Analysis (USD MN)
  •  South Africa Market Analysis (USD MN)
  •  Rest of Middle East and Africa Market Analysis (USD MN)
  •  Partnership/Collaboration/Agreement
  •  Mergers And Acquisition
 
 LIST OF FIGURES
 
  •  Research Scope of Rheumatoid Arthritis Report
  •  Market Research Process
  •  Market Research Methodology
  •  Global Rheumatoid Arthritis Market Size, by Region (USD MN)
  •  Porters Five Forces Analysis
  •  Market Attractiveness Analysis by Treatment
  •  Market Attractiveness Analysis by Distribution Channel
  •  Market Attractiveness Analysis by Region
  •  Value Chain Analysis
  •  Global Market Analysis by Treatment (USD MN)
  •  Symptomatic Treatment Market Sales by Geography (USD MN)
  •  Intermediate Corticosteroid Treatment Market Sales by Geography (USD MN)
  •  Disease Modifying Anti-Rheumatic Drug {DMARD} Therapies Market Sales by Geography (USD MN)
  •  Global Market Analysis by Distribution Channel (USD MN)
  •  Hospital Pharmacies Market Sales by Geography (USD MN)
  •  Retail Pharmacies Market Sales by Geography (USD MN)
  •  Drug Stores Market Sales by Geography (USD MN)
  •  Global Market by Revenue
  •  North America Market by Revenue
  •  Europe Market by Revenue
  •  Asia Pacific Market by Revenue
  •  Latin America Market by Revenue
  •  Middle East & Africa Market by Revenue
  •  Recent Development in Industry
  •  Top Companies Market Share Analysis
 
 * Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Objectives of Study

  • Define and measure the global market
  • Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
  • Analyze and identify major market trends along with the factors driving or inhibiting the market growth
  • Study the company profiles of the major market players with their market share
  • Analyze competitive developments

Why Choose Us

Client First Policy
Excellent Quality
After Sales Support
24/7 Email Support

Clients

Testimonials